Broncus Holding (HKSE:02216) Other Net Income (Loss) : HK$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Broncus Holding Other Net Income (Loss)?

Broncus Holding's Other Net Income (Loss) for the six months ended in Dec. 2024 was HK$0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00 Mil.

Broncus Holding's quarterly Other Net Income (Loss) declined from Dec. 2023 (HK$0.01 Mil) to Jun. 2024 (HK$0.00 Mil) but then stayed the same from Jun. 2024 (HK$0.00 Mil) to Dec. 2024 (HK$0.00 Mil).

Broncus Holding's annual Other Net Income (Loss) declined from Dec. 2022 (HK$0.00 Mil) to Dec. 2023 (HK$-0.00 Mil) but then increased from Dec. 2023 (HK$-0.00 Mil) to Dec. 2024 (HK$0.00 Mil).

Broncus Holding Other Net Income (Loss) Historical Data

The historical data trend for Broncus Holding's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Broncus Holding Other Net Income (Loss) Chart

Broncus Holding Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Broncus Holding Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial						-	-	0.01	-	-

Broncus Holding Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

Broncus Holding Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Broncus Holding's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Broncus Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Broncus Holding Corp (HKSE:02216) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88 Jiangling Road, Xixing Street, Room 801, 8th Floor, Building 8, Binjiang District, Hangzhou, CHN

Website

https://www.broncus.com

Broncus Holding Corp is a medical device company focused on the development of interventional pulmonology products. It is engaged in the field of interventional pulmonology, providing lung solutions in China and globally. The integrated interventional pulmonology platform addresses the pain points of the existing diagnosis and treatment paradigms and unmet medical needs for lung diseases by improving the diagnosis and treatment effects of lung cancer and COPD. The company offers products like Archimedes System, LungPoint, BioStar, FleXNeedle Biopsy Needle, RF-II, and InterVapor System among others. Geographically, the company derives a majority of its revenue from the Chinese Mainland, and the rest from European Union, USA, and other regions.

Executives

Xu Hong	2101 Beneficial owner
Zi Zhenjun
Xin Nuo Tong Investment Limited	2201 Interest of corporation controlled by you
Qiming Corporate Gp Iv, Ltd.	2201 Interest of corporation controlled by you
Qiming Venture Partners Iv, L.p.	2101 Beneficial owner
Qiming Gp Iv, L.p.	2201 Interest of corporation controlled by you
Qm12 Limited	2101 Beneficial owner
Dinova Capital Limited
Dinova Venture Partners Gp Iii, L.p.
Broncus Biomedical Limited
Dinova Healthcare Gamma Fund (usd) L.p.
Computershare Hong Kong Trustees Limited	2301 Trustee
Dinova Healthcare (hong Kong) Co., Limited
Lake Bleu Capital (hong Kong) Limited	2102 Investment manager
Hang Zhou De Nuo Shang Wu Zi Xun Zi Xun You Xian Gong Si

Broncus Holding Headlines

No Headlines